BR9811298A - Uso de um composto de vanádio fisiologicamente aceitável - Google Patents
Uso de um composto de vanádio fisiologicamente aceitávelInfo
- Publication number
- BR9811298A BR9811298A BR9811298-8A BR9811298A BR9811298A BR 9811298 A BR9811298 A BR 9811298A BR 9811298 A BR9811298 A BR 9811298A BR 9811298 A BR9811298 A BR 9811298A
- Authority
- BR
- Brazil
- Prior art keywords
- physiologically acceptable
- vanadium compound
- acceptable vanadium
- surrounding tissue
- injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
"USO DE UM COMPOSTO DE VANáDIO FISIOLOGICAMENTE ACEITáVEL". Uso de um composto de vanádio fisiologicamente aceitável, sal ou complexo como um componente ativo na preparação de uma composição farmacêutica para o tratamento profilático de dano secundário de tecido, referido dano secundário sendo induzido por dano primário de tecido principalmente circundante, particularmente tecido circundante, e sendo o resultado de um evento traumático.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL1006681A NL1006681C2 (nl) | 1997-07-29 | 1997-07-29 | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
PCT/NL1998/000431 WO1999006056A1 (en) | 1997-07-29 | 1998-07-29 | Use of physiologically acceptable vanadium compounds, salts and complexes |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9811298A true BR9811298A (pt) | 2000-08-29 |
Family
ID=19765422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9811298-8A BR9811298A (pt) | 1997-07-29 | 1998-07-29 | Uso de um composto de vanádio fisiologicamente aceitável |
Country Status (22)
Country | Link |
---|---|
US (2) | US6579540B1 (pt) |
EP (1) | EP1001792B1 (pt) |
JP (1) | JP2001511454A (pt) |
CN (1) | CN1104244C (pt) |
AT (1) | ATE253373T1 (pt) |
AU (1) | AU738701B2 (pt) |
BR (1) | BR9811298A (pt) |
CA (1) | CA2298645C (pt) |
CZ (1) | CZ299716B6 (pt) |
DE (1) | DE69819514T2 (pt) |
DK (1) | DK1001792T3 (pt) |
EA (1) | EA002574B1 (pt) |
ES (1) | ES2207851T3 (pt) |
ID (1) | ID24870A (pt) |
IL (2) | IL134259A0 (pt) |
NL (1) | NL1006681C2 (pt) |
NO (1) | NO20000446L (pt) |
NZ (1) | NZ502613A (pt) |
PL (1) | PL338415A1 (pt) |
PT (1) | PT1001792E (pt) |
TR (1) | TR200000349T2 (pt) |
WO (1) | WO1999006056A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1006681C2 (nl) * | 1997-07-29 | 1999-02-08 | Gho St Holding Bv | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
US8192994B2 (en) * | 1998-02-10 | 2012-06-05 | Angros Lee H | Method of applying a biological specimen to an analytic plate |
WO2001045716A1 (en) * | 1999-12-20 | 2001-06-28 | Gho'st Holding B.V. | Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor |
WO2003041703A2 (en) * | 2001-11-16 | 2003-05-22 | Gho Holding B.V. | Use of a flavonoid for the treatment of burns |
ES2485384T3 (es) | 2007-01-31 | 2014-08-13 | Basf Plant Science Gmbh | Plantas que tienen rasgos potenciados relacionados con el rendimiento y/o mayor resistencia al estrés abiótico y un procedimiento para fabricar las mismas |
ES2542311T3 (es) | 2007-05-03 | 2015-08-04 | Basf Plant Science Gmbh | Plantas que tienen rasgos potenciados relacionados con el rendimiento y un procedimiento de producción de las mismas |
EP2987861A1 (en) | 2007-07-20 | 2016-02-24 | BASF Plant Science GmbH | Plants having increased yield-related traits and a method for making the same |
AR067748A1 (es) | 2007-07-31 | 2009-10-21 | Basf Plant Science Gmbh | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas |
MX2010004305A (es) | 2007-10-29 | 2010-04-30 | Basf Plant Science Gmbh | Plantas que tienen rasgos relacionados con el rendimiento aumentado y un metodo para producirlas. |
EP2274431A1 (en) | 2008-05-05 | 2011-01-19 | BASF Plant Science GmbH | Plants having enhanced yield-related traits and a method for making the same |
US20100078320A1 (en) * | 2008-09-26 | 2010-04-01 | Applied Materials, Inc. | Microwave plasma containment shield shaping |
EP2523672B1 (en) | 2010-01-15 | 2016-07-13 | Rutgers, the State University of New Jersey | Use of vanadium compounds to accelerate bone healing |
US20140322292A1 (en) | 2010-12-10 | 2014-10-30 | Rutgers, The State University Of New Jersey | Insulin-mimetics as therapeutic adjuncts for bone regeneration |
CA2820297C (en) | 2010-12-10 | 2019-06-25 | University Of Medicine And Dentistry Of New Jersey | Implantable devices coated with insulin-mimetic agent composites and methods thereof |
AU2012226703A1 (en) | 2011-03-07 | 2013-10-17 | Cfm Pharma Holding Bv | Use of vanadium compounds for maintaining normaglycemia in a mammal |
US9931348B2 (en) * | 2011-07-06 | 2018-04-03 | Rutgers, The State University Of New Jersey | Vanadium compounds as therapeutic adjuncts for cartilage injury and repair |
PL231079B1 (pl) | 2012-11-07 | 2019-01-31 | Univ Jagiellonski | Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami |
NL2019605B1 (en) * | 2017-09-22 | 2019-03-28 | Cfm Pharma Holding B V | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5448490A (en) * | 1989-04-24 | 1990-11-16 | Board Of Regents, The University Of Texas System | Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue |
US5565491A (en) * | 1994-01-31 | 1996-10-15 | Bristol-Myers Squibb Company | Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
FR2729957B1 (fr) * | 1995-01-31 | 1997-12-05 | Maurel Sante | Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant. |
NL1006681C2 (nl) * | 1997-07-29 | 1999-02-08 | Gho St Holding Bv | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
-
1997
- 1997-07-29 NL NL1006681A patent/NL1006681C2/nl not_active IP Right Cessation
-
1998
- 1998-07-29 CN CN98809293A patent/CN1104244C/zh not_active Expired - Fee Related
- 1998-07-29 IL IL13425998A patent/IL134259A0/xx unknown
- 1998-07-29 CZ CZ20000326A patent/CZ299716B6/cs not_active IP Right Cessation
- 1998-07-29 PT PT98937862T patent/PT1001792E/pt unknown
- 1998-07-29 BR BR9811298-8A patent/BR9811298A/pt not_active Application Discontinuation
- 1998-07-29 ES ES98937862T patent/ES2207851T3/es not_active Expired - Lifetime
- 1998-07-29 CA CA002298645A patent/CA2298645C/en not_active Expired - Fee Related
- 1998-07-29 PL PL98338415A patent/PL338415A1/xx unknown
- 1998-07-29 EP EP98937862A patent/EP1001792B1/en not_active Expired - Lifetime
- 1998-07-29 JP JP2000504869A patent/JP2001511454A/ja active Pending
- 1998-07-29 NZ NZ502613A patent/NZ502613A/en not_active IP Right Cessation
- 1998-07-29 AU AU86505/98A patent/AU738701B2/en not_active Ceased
- 1998-07-29 TR TR2000/00349T patent/TR200000349T2/xx unknown
- 1998-07-29 ID IDW20000183A patent/ID24870A/id unknown
- 1998-07-29 AT AT98937862T patent/ATE253373T1/de not_active IP Right Cessation
- 1998-07-29 WO PCT/NL1998/000431 patent/WO1999006056A1/en active IP Right Grant
- 1998-07-29 DK DK98937862T patent/DK1001792T3/da active
- 1998-07-29 US US09/463,697 patent/US6579540B1/en not_active Expired - Lifetime
- 1998-07-29 EA EA200000176A patent/EA002574B1/ru not_active IP Right Cessation
- 1998-07-29 DE DE69819514T patent/DE69819514T2/de not_active Expired - Lifetime
-
2000
- 2000-01-27 IL IL134259A patent/IL134259A/en not_active IP Right Cessation
- 2000-01-28 NO NO20000446A patent/NO20000446L/no not_active Application Discontinuation
-
2003
- 2003-04-21 US US10/419,914 patent/US20030211170A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NO20000446L (no) | 2000-03-24 |
ATE253373T1 (de) | 2003-11-15 |
TR200000349T2 (tr) | 2000-09-21 |
WO1999006056A1 (en) | 1999-02-11 |
PT1001792E (pt) | 2004-03-31 |
PL338415A1 (en) | 2000-11-06 |
US6579540B1 (en) | 2003-06-17 |
CZ2000326A3 (cs) | 2000-07-12 |
EP1001792B1 (en) | 2003-11-05 |
IL134259A (en) | 2010-02-17 |
NL1006681C2 (nl) | 1999-02-08 |
NZ502613A (en) | 2001-08-31 |
EA200000176A1 (ru) | 2000-10-30 |
CA2298645C (en) | 2004-05-18 |
ID24870A (id) | 2000-08-31 |
EP1001792A1 (en) | 2000-05-24 |
AU8650598A (en) | 1999-02-22 |
JP2001511454A (ja) | 2001-08-14 |
US20030211170A1 (en) | 2003-11-13 |
CA2298645A1 (en) | 1999-02-11 |
AU738701B2 (en) | 2001-09-27 |
DE69819514D1 (de) | 2003-12-11 |
CN1270525A (zh) | 2000-10-18 |
DE69819514T2 (de) | 2004-09-23 |
ES2207851T3 (es) | 2004-06-01 |
EA002574B1 (ru) | 2002-06-27 |
NO20000446D0 (no) | 2000-01-28 |
IL134259A0 (en) | 2001-04-30 |
CZ299716B6 (cs) | 2008-10-29 |
DK1001792T3 (da) | 2004-01-19 |
CN1104244C (zh) | 2003-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9811298A (pt) | Uso de um composto de vanádio fisiologicamente aceitável | |
UA56989C2 (uk) | ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ | |
AR052921A1 (es) | Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica | |
WO1995031985A3 (en) | Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies | |
PT948527E (pt) | Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
PT979244E (pt) | Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem | |
ATE252081T1 (de) | Neue hiv-protease-inhibitoren | |
UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
DE69932510D1 (de) | Vaskularisierungsinhibitoren | |
BR0013009A (pt) | Uso de antagonistas de cgrp e de inibidores de liberação de cgrp para combate a jatos quentes menopáusicos | |
EP1008344A4 (en) | USE OF A NEW BICAFEOYLQUINIC ACID IN THE TREATMENT OF HEPATITIS B AND RETROVIRUS-RELATED DISEASES AND DERIVATIVES OF THIS BICAFEOLYQUINIC ACID | |
ECSP930933A (es) | Composicion farmaceutica y procedimiento para prepararla | |
HUP0103819A3 (en) | Crystalline efavirenz pharmaceutical compositions containing it as active ingredient, and use of efavirenz for making medicament available for inhibitions of reverse transcriptase and for treating hiv infection | |
BR0007452A (pt) | Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação | |
BR0207066A (pt) | Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles | |
TR200102512T2 (tr) | Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı. | |
WO1999051256A3 (en) | Use of l-glu-l-trp in the treatment of hiv infection | |
AU5539798A (en) | Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them | |
CA2385755A1 (en) | Prevention of colorectal cancer | |
PL339073A1 (en) | Derivatives of benzoxazine and benzothiazine and their application in therapeutic agents | |
BR0115983A (pt) | Uso de sarp-1 para o tratamento e/ou prevenção de escleroderma | |
BR0115911A (pt) | Uso de pirazolo[4,3-d]pirimidinas | |
BR0309055A (pt) | Uso combinado de l-carnitina, acetil l-carnitina e propionil l-carnitina para o tratamento da oligoastenoteratospermia | |
BR0303384A (pt) | Citalopram e seus usos no tratamento de pressão sanguìnea elevada | |
UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |